Open Access
Inauguraldissertation zur Erlangung der Würde eines Doktors der Philosophie vorgelegt der
Medizinischen Fakultät
- 01 Jan 2012
TL;DR: Fiedler et al. as discussed by the authors proposed VIP36, a novel component of TGN-derived exocytic carrier vesicles and glycolipid-enriched rafts in MDCK cells.
read more
Abstract: Fiedler, K., and K. Simons (1992) Protein sorting and detergent-insoluble complexes in MDCK cells. American Society for Cell Biology, Denver, Colorado, U.S.A. November 1992. Mol. Biol. of the Cell 3, supplement p308. Fiedler, K., Kellner, R., Dupree, P., Etzold, T., and K. Simons (1993) VIP36, a novel component of TGN-derived exocytic carrier vesicles and glycolipid-enriched rafts in MDCK cells. American Society for Cell Biology, New Orleans, U.S.A. December 1993. Mol. Biol. of the Cell 4, supplement p209.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
•Journal Article
Pharmacokinetics of galanthamine, a long-acting anticholinesterase drug, in anesthetized patients
TL;DR: The pharmacokinetics of the long-acting anticholinesterase drug, Galanthamine, were investigated in eight patients as discussed by the authors, and the decrease in the serum concentration of galanthamine followed a biexponential curve.
27
•Dissertation
The expression of Na, K-ATPase in the Madin-Darby canine kidney (MDCK) cell line
Christopher Paul Cutler
- 01 Jan 1991
17
Iconographies supplémentaires de l'article : Down-regulation of IL-12 by topical corticosteroids in chronic atopic dermatitis
Nikhil Yawalkar,Stephan Karlen,Fabienne Egli,C. U. Brand,Hans U. Graber,Werner J. Pichler,Lasse R. Braathen +6 more
- 09 Apr 2011
TL;DR: In this paper, the precise in situ localization of IL-12 and its modulation under topical treatment with corticosteroids were delineated and shown to be significantly enhanced in lesional skin from atopic dermatitis.
1
References
•Journal Article
Receptor-binding profiles of antipsychotics: clinical strategies when switching between agents.
TL;DR: An understanding of the differential receptor-binding profiles of the various antipsychotics can help clinicians anticipate and manage potential clinical issues that may be encountered when switching antipsychotic therapy.
Clinical pharmacology of 4-demethoxydaunorubicin (DMDR).
Katherine Lu,Niramol Savaraj,John J. Kavanagh,Lynn G. Feun,Michael A. Burgess,Gerald P. Bodey,Ti Li Loo +6 more
TL;DR: DMDR, a daunorubicin derivative with a higher therapeutic index and lower cardiotoxicity than either the parent drug or doxorubilicin, is active when given PO in experimental animals and its pharmacokinetics are studied.
44
Etoposide (VP 16-213) induced hepatitis. Report of three cases following standard-dose treatments.
TL;DR: Three cases of severe hepatocellular necrosis following administration of standard doses of Etoposide (VP 16-213) are reported.
44
No effect of dose, hepatic function, or nutritional status on 5-FU clearance following continuous (5-day), 5-FU infusion.
Ronald A. Fleming,Gérard Milano,Marie-Christine Etienne,Nicole Renée,Antoine Thyss,Maurice Schneider,F Demard +6 more
TL;DR: Results show that laboratory data including indices of hepatic function and nutritional status cannot account for the interpatient variability in 5-FU disposition.
43
Pharmacokinetics of idarubicin (4-demethoxydaunorubicin; IMI-30; NSC 256439) following intravenous and oral administration in patients with advanced cancer.
TL;DR: Plasma concentrations of idarubicinol (the only metabolite detected) rapidly exceeded those of the parent drug, and exposure to this metabolite was greater than to the parentDrug.